CentraLabS Clinical Research is an emerging force supporting global drug development in the pharmaceutical industry. Part of the Life Sciences Research group of companies, CentraLabS has evolved from the clinical laboratory services arm of one of the worlds longest established CROs. This has allowed CentraLabS to utilise its extensive analytical experience to provide focus and dedicated support to all stages of clinical drug development.
Our group company has over 30 years experience in providing analytical support for clinical studies to the pharmaceutical industry. CentraLabS Clinical Research began its operations in the 1990s when the clinical pathology laboratories of Ciba-Geigy Pharmaceuticals UK were acquired. At that time Life Sciences had been supporting Phase I studies for at least five years. These two laboratories were consolidated in the east of England during 1998 and the Central Laboratory Services group was born.
Over the last 5 years we have expanded the scope of our analytical service to include logistics, project and data management to support full global clinical trials. In 2000 our USA clinical laboratory in Princeton New Jersey came on line and in 2001 we launched our global operation under the CentraLabS Clinical Research name.
Working in modern laboratories with purpose-designed and state of the art equipment, our teams of technical and scientific experts produce data that will meet the most exacting regulatory requirements. The quality of their work is reflected in a history of compliance with Good Laboratory Practice (GLP) dating back to 1977.
With a completely flexible approach to working with our sponsors CentraLabS can provide additional capacity to meet a short term increase in workload or undertake the complete management of the study using experienced project co-ordination staff. Therefore, however great or little the task, we can ensure it is performed on time, correct in all its details and reported in a form that is immediately acceptable to regulatory authorities.
Mission Statement
To provide a comprehensive range of integrated development services which are recognised to be of superior value by our customers in the pharmaceutical industry. This is by enhancing regulatory acceptance, speed to market and return on investment of their products.
Business Development Strategy
- Consolidate market leadership for clinical testing across current customer base
- Extend services to support clinical development
- Introduce additional services to support clinical sample testing
- Enhance range of services and expertise to support drug compound development